Frank, Jeffrey Evan (Author)
The evolution of late twentieth century scientific discovery produced a series of connected paradigms spawning a new biotechnology industry, founded on molecular biology, genetics and related scientific disciplines producing a revolution in human medical care and expectations that remarkable advances lie ahead. This research uses establishment data to examine the geography and properties of the U.S. biotechnology industry at three scales, culminating in the formulation of a conceptual model of the new biotechnology industry. A national analysis develops overall industry characteristics and locational patterns. The distribution of federal research funds from the National Institutes of Health is examined for its influence on the industry. A regional analysis of the Washington-Baltimore Metropolitan Area documents the two-decade emergence of this region as a leading component of the U.S. industry. Unique factors stimulate a strong regional economy and a productive set of incubator conditions through the presence of the federal government, especially the National Institutes of Health, to support the growth of the biotechnology sector and the formation of a large information-based technology sector. Standardized case studies of five regional firms confirm a pattern of business and scientific behavior that, combined with the national and regional analyses, are used to formulate a conceptual industry model generalizing industry characteristics and behavior. The model links scientific and entrepreneurial motivations, the role of federal research expenditures, and federal regulatory approval of the products coming from these new biotechnology firms. Start-up companies are shown operating in a highly competitive international marketplace of product development that is uniquely regulated. New firms are shown to sustain themselves through a process that relies on creative financing with a strong reliance on collaborative agreements, which in some respects, demonstrate locational patterns that are inconsistent with behavior found in other technology sectors. The economic behavior and regulatory environment impacting these new businesses has implications for national, state and local governmental support and oversight, as scientific discoveries of entrepreneurially driven companies place themselves at the apex of human science in the twenty-first century. Policy implications are suggested in a concluding element of the thesis.
...MoreDescription Cited in Diss. Abstr. Int. A 62 (2002): 4282. UMI order no. 3035778.
Book
Hughes, Sally Smith;
(2011)
Genentech: The Beginnings of Biotech
(/isis/citation/CBB001221219/)
Article
Bud, Robert;
(2010)
From Applied Microbiology to Biotechnology: Science, Medicine and Industrial Renewal
(/isis/citation/CBB001022750/)
Article
Welsh, Rick;
Glenna, Leland;
(2006)
Considering the Role of the University in Conducting Research on Agri-biotechnologies
(/isis/citation/CBB000780215/)
Thesis
Gozubuyuk, Remzi;
(2007)
The Position of the Firm in Scientific and Alliance Networks: Social Structural Determinants of Innovation in the United States Biotechnology Industry, 1990--2002
(/isis/citation/CBB001561531/)
Article
Yi, Doogab;
(2009)
The Scientific Commons in the Marketplace: The Industrialization of Biomedical Materials at the New England Enzyme Center, 1963--1980
(/isis/citation/CBB000931983/)
Article
Chadarevian, Soraya de;
(2011)
The Making of an Entrepreneurial Science: Biotechnology in Britain, 1975--1995
(/isis/citation/CBB001220015/)
Book
Berman, Elizabeth Popp;
(2012)
Creating the Market University: How Academic Science Became an Economic Engine
(/isis/citation/CBB001201809/)
Book
Martini, Edwin A.;
(2012)
Agent Orange: History, Science, and the Politics of Uncertainty
(/isis/citation/CBB001320939/)
Book
Hirt, Paul W.;
(2012)
The Wired Northwest: The History of Electric Power, 1870s--1970s
(/isis/citation/CBB001201248/)
Article
Gelfert, Axel;
(2013)
Before Biopolis: Representations of the Biotechnology Discourse in Singapore
(/isis/citation/CBB001253170/)
Article
Jones, Mark Peter;
(2009)
Entrepreneurial Science: The Rules of the Game
(/isis/citation/CBB000953584/)
Article
Jong, Simcha;
(2006)
How Organizational Structures in Science Shape Spin-off Firms: The Biochemistry Departments of Berkeley, Stanford, and UCSF and the Birth of the Biotech Industry
(/isis/citation/CBB000742074/)
Article
Hughes, Sally Smith;
(2001)
Making Dollars out of DNA: The First Major Patent in Biotechnology and the Commercialization of Molecular Biology, 1974--1980
(/isis/citation/CBB000671241/)
Book
Carlson, Robert H.;
(2010)
Biology Is Technology: The Promise, Peril, and New Business of Engineering Life
(/isis/citation/CBB001251428/)
Chapter
Reilly, Philip R.;
(2008)
The How of Biotechnology
(/isis/citation/CBB000953886/)
Book
Ton van Helvoort;
Eric Berkers;
Mila Davids;
(2017)
Biotechnologie: van wetenschap naar winkelschap revisited: een historische analyse van de Biotech bij multinational Unilever
(/isis/citation/CBB491047684/)
Book
Jasanoff, Sheila;
(2005)
Designs on Nature: Science and Democracy in Europe and the United States
(/isis/citation/CBB000641621/)
Book
Vettel, Eric James;
(2006)
Biotech: The Countercultural Origins of an Industry
(/isis/citation/CBB000772101/)
Book
Charles, Daniel;
(2003)
Lords of the Harvest: Biotech, Big Money, and the Future of Food
(/isis/citation/CBB000301884/)
Thesis
Moxley, Shera A.;
(2012)
Designer Drugs: Rational Therapeutics in the Biotechnology Era, 1973--1997
(/isis/citation/CBB001561025/)
Be the first to comment!